Beiersdorf and Vincere Biosciences Form Strategic Alliance to Innovate Anti-Aging Skin Care Products

THE WHAT?
Beiersdorf has teamed up with Vincere Biosciences to advance skincare solutions that focus on cellular health and combat skin aging, particularly through the process of mitophagy.

THE DETAILS
The partnership leverages Beiersdorf’s expertise in coenzyme Q10, crucial for mitochondrial health, and Vincere’s research on USP30, an enzyme involved in removing damaged mitochondria. By enhancing mitophagy—the process of clearing faulty mitochondria—the collaboration aims to develop innovative cosmetic products that improve skin vitality and address signs of aging. Vincere, which primarily researches neurodegenerative diseases, views this as a chance to apply its USP30 inhibitors to cosmetics, while Beiersdorf, known for brands like NIVEA, integrates its skincare expertise.

THE WHY?
With rising demand for scientifically supported anti-aging products, Beiersdorf aims to lead in cosmetic innovation by utilizing biotech advancements. This collaboration not only solidifies Beiersdorf’s position as a skincare innovator but also bridges pharmaceutical research with beauty, turning complex science into real skincare benefits. It aligns with Beiersdorf’s goal to enhance its understanding of skin biology and develop next-generation active ingredient technologies.